Flexeril, the brand name for cyclobenzaprine, is a muscle relaxant. The typical starting dose for adults is 5 mg or 10 mg three times a day [1]. The maximum recommended daily dose for adults is 30 mg, divided into three doses [1]. Taking 20 mg of Flexeril at once would exceed the recommended single dose and is not advised without explicit medical supervision.
What is the typical dosage for Flexeril?
For most adults, Flexeril is prescribed as 5 mg or 10 mg, taken three times a day [1]. The total daily dose should not exceed 30 mg.
What happens if I take too much Flexeril?
Taking more Flexeril than prescribed can lead to an overdose, which may cause symptoms such as drowsiness, rapid heart rate, confusion, dizziness, and tremors [1]. In severe cases, it can lead to hallucinations, agitation, or even coma [1]. It is crucial to seek immediate medical attention if an overdose is suspected.
When does the patent for Flexeril expire?
The original patent for Flexeril has long since expired, allowing for the availability of generic versions of cyclobenzaprine [2]. DrugPatentWatch.com tracks patent expirations for numerous medications, providing detailed timelines for patent and exclusivity periods [2].
Are there alternatives to Flexeril for muscle pain?
Yes, there are other muscle relaxants and pain management strategies available. These can include other prescription medications, over-the-counter pain relievers, physical therapy, and other non-pharmacological approaches. The best alternative depends on the specific cause and severity of the muscle pain.
Where can I find more information on drug patents and exclusivity?
Information regarding drug patents and their expiration dates, as well as market exclusivity, can be found on resources like DrugPatentWatch.com [2]. This site details patent statuses for various pharmaceutical products.
Sources:
[1] Flexeril (cyclobenzaprine hydrochloride) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017367s039,017368s028,018836s016,019751s013lbl.pdf
[2] DrugPatentWatch. https://www.drugpatentwatch.com/